Avandia Information Center: __________________ Avandia Alert FDA’s Evaluation of AVANDIA Injured by Avandia? 'Black Box' Warning for Avandia

The FDA will require more warnings on the label for Avandia about heart failure on the diabetes drug Avandia. The FDA revealed that it is ordering GlaxoSmithKline to add a "black box" warning to
Avandia. It is also ordering Takeda Pharmaceuticals to do the same for its competing diabetes drug Actos.

The controversy over Avandia has intensified when a medical expert told the House Committee on Oversight and Government Reform that executives with GlaxoSmithKline threatened to sue him in 1999 when he first drew attention to heart attack risks linked to Avandia.

Despite additional warnings from outside experts, despite the millions of patients who rely on Avandia to
control their blood sugar, and despite the potential risks involved, FDA never required the manufacturer to
conduct a thorough post-market study of its heart risks.

If you or a loved one has suffered a heart attack, while taking Avandia, call us a t 1-800-862-1260.